Replay available

Sotera Health Company (SHC) Q4 2025 Earnings Call

Sotera Health Company (NASDAQ: SHC) Q4 2025 earnings conference call, held 2026-02-24. Replay captured from the company's public earnings webcast.

Tue, February 24, 2026 at 9:00 AMendedReplay
Sotera Health Company (SHC) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Jason Peterson

Vice President of Investor Relations

Michael Petras

Chairman and Chief Executive Officer

John Lyons

Chief Financial Officer

Sean Dodge

Analyst, BMO Capital Markets

Patrick Donnelly

Analyst, Citi

Brett Fishman

Analyst, KeyBank

Christine Raines

Analyst, William Blair

Casey Woodring

Analyst, JP Morgan

Jason Bednar

Analyst, Piper Sandler

Ryan Halstead

Analyst, RBC Capital Markets

David Windley

Analyst, Jefferies

Replay transcript excerpt

Good morning and welcome to Terra Health fourth quarter and full year 2025 conference call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question, please press star then 1-1 on your touchtone phone. To withdraw your question, please press star 1-1 again. Please note this event is being recorded. I would now like to turn the conference over to Vice President of Investor Relations, Jason Peterson. Jason, please go ahead. Good morning and thank you. Welcome to Soterra Health's fourth quarter and four-year 2025 earnings call. Today's press release and supplemental slides are available on the investor section of our website at soterrahealth.com. This webcast is being recorded and a replay will also be available on the investor section of the Soterra Health website shortly after the call. Joining me today are Chairman and Chief Executive Officer Michael Petras and Chief Financial Officer John Lyons. During the call today, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotero Health SEC filings in the forward-looking statement slide at the beginning of the presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements. Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, tax rate applicable to net income, adjusted net income, adjusted EPS, adjusted free cash flow, net debt and net leverage ratio, as...

More from Sotera Health Company